Budralazine

Budralazine
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name N-(4-methylpent-3-en-2-ylideneamino)phthalazin-1-amine;
CAS Number	36798-79-5;
PubChem CID	6419536;
ChemSpider	4925205;
UNII	S0177QHV2B;
ChEMBL	ChEMBL2107516;
CompTox Dashboard (EPA)	DTXSID00865833 ;
Chemical and physical data
Formula	C14H16N4
Molar mass	240.310 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES n2nc(c1ccccc1c2)N/N=C(/C=C(\C)C)C;

Budralazine (INN) is a vasodilator.^[1]^[2]

References

^ Akashi A, Chiba T, Suzuki I, Hashimoto H (September 1978). "Pharmacology of budralazine, a new antihypertensive drug". Archives Internationales de Pharmacodynamie et de Thérapie. 235 (1): 134–46. PMID 736687.
^ Yoshioka M, Minami M, Saito H (1991). "The anti-tachycardic mechanism of a direct-acting vasodilator, budralazine, in rats". Clinical and Experimental Hypertension, Part A. 13 (5): 1107–14. doi:10.3109/10641969109042116. PMID 1773498.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.